Frontlight ResearchEarly access
Taking people in PolandPhase 1
Safety and Effects of LFD-200 in Healthy People and People With Rheumatoid Arthritis
Tests different doses of LFD-200 in healthy adults and adults with rheumatoid arthritis.
Key facts
- Who runs it
- Lifordi Immunotherapeutics Inc.
- Where
- Torun and Warsaw, PolandSee the 2 sites
- Trial code
- Registry title
- A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 40 people, planned
- Started
- 6 Oct 2026
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional
- Record updated
- 28 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy adults and adults with moderate to severe rheumatoid arthritis. It tests how safe different doses of LFD-200 are and how it works.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Moderate to severe rheumatoid arthritis (healthy people can also join)
Where in Poland
- Medicover Integrated Clinical Services Sp. z o.o.Torun, PolandTaking people
- Klinika Reuma Park Sp. z o.o. S.K.Warsaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Safety and Effects of LFD-200 in Healthy People and People With Rheumatoid ArthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 28 August 2026